Elevation Spine wins FDA 510(k) clearance for 3D-printed titanium cervical implant Saber-C AVIA

Elevation Spine has received FDA 510(k) clearance for its Saber-C AVIA implant system, a 3D-printed titanium intervertebral body designed for anterior cervical discectomy and fusion (ACDF). The additively manufactured device uses a lattice architecture with 55% porosity intended to mimic trabecular bone structure and support bone ingrowth, though the company cites preclinical data rather than conclusive clinical benefit. The zero-profile design avoids the need for a traditional anterior plate, with integrated spikes or screws for primary fixation, and variants offer six degrees of lordosis or twelve degrees of hyperlordosis.

The clearance extends Elevation Spine's presence in the cervical fusion market by adding a porous titanium option to its existing Saber-C platform. The company redesigned the surgical instrument set with dedicated tools for spike insertion and a flat inserter for screws, both packaged in a common sieve to allow intraoperative fixation adjustments. CEO Charlie Gilbride emphasized that surgeon feedback from the existing Saber-C community directly shaped the development, highlighting how smaller firms can iterate faster than larger orthopedics players on implant design and instrumentation.

The practical test for Saber-C AVIA will be whether clinical follow-up data confirm fusion rates, mechanical stability, and OR handling comparable to or better than existing PEEK or solid titanium interbody devices. The 510(k) pathway means Elevation Spine demonstrated substantial equivalence to a predicate device, not de novo clinical superiority, so post-market surveillance will determine whether the porous architecture delivers measurable patient outcomes. For hospital purchasing committees, the zero-profile design and integrated fixation may reduce operative time and implant cost versus separate plate-and-cage systems, but adoption will depend on surgeon familiarity and reimbursement alignment.